Trulieve Cannabis (TCNNF) Interest & Investment Income (2023 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Interest & Investment Income of $2.7 million in Q1 2026, down 21.52% quarter-over-quarter from $3.4 million in Q4 2025, and down 12.52% on a YoY basis from $3.1 million in Q1 2025.
Trulieve Cannabis (TCNNF) Interest & Investment Income (2023 - 2026) Analysis & Trends
Trulieve Cannabis' Interest & Investment Income history runs 4 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 12.52% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $14.1 million (down 2.43% YoY), while the FY2025 annual figure was $14.5 million, down 1.08% from the prior year.
- Interest & Investment Income was $2.7 million for Q1 2026 at Trulieve Cannabis, down from $3.4 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $4.4 million in Q3 2025 to a low of $1.1 million in Q1 2023.
- Historically, Interest & Investment Income has averaged $2.9 million across 4 years, with a median of $3.2 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Interest & Investment Income jumped 206.78% in 2024, then dropped 12.52% in 2026.
- A 4-year view of Interest & Investment Income shows it stood at $1.8 million in 2023, then surged by 72.68% to $3.2 million in 2024, then gained by 7.58% to $3.4 million in 2025, then fell by 21.52% to $2.7 million in 2026.
- The last three Interest & Investment Income figures came in at $2.7 million (Q1 2026), $3.4 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | 2.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.68 Mn |
| Dec 31, 2025 | 3.42 Mn |
| Sep 30, 2025 | 4.39 Mn |
| Jun 30, 2025 | 3.64 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Dec 31, 2024 | 3.18 Mn |
| Sep 30, 2024 | 4.20 Mn |
| Jun 30, 2024 | 4.04 Mn |
| Mar 31, 2024 | 3.26 Mn |
| Dec 31, 2023 | 1.84 Mn |
| Sep 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.06 Mn |